Navigating ALK-positive Clinical Trials: Facts Timelines, and Real Expectations Jonathan Riess, MD, MS, is the Director of Thoracic Oncology at the UC Davis Comprehensive Cancer Center and has extensive experience caring for ALK+ patients, having served as an investigator on most ALK+ lung cancer clinical trials. He is joined by Johanna Han, MSc, CCRP, Assistant […]

